Transcode Therapeutics Inc Cash Flow Quality Index
Latest as of June 2021:
-0.06x
Transcode Therapeutics Inc cash flow quality index. Transcode Therapeutics Inc (RNAZ) has a Cash Flow Quality Index of -0.06x as of June 2021. Operating cash flow of $-161.66K is below net income of $2.77 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of Transcode Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-0.06x
Operating CF / Net Income
Operating Cash Flow
$-161.66K
USD
Net Income
$2.77 Million
USD
Data as of
Jun 2021
Most recent filing
Transcode Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Transcode Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Transcode Therapeutics Inc. For the full cash flow conversion analysis, see RNAZ cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.